GenMark Diagnostics to Present at the William Blair 36th Annual Growth Stock Conference
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive Officer, will present at the William Blair 36th Annual Growth
Stock Conference to be held in Chicago, Illinois at the Four Seasons Hotel on Wednesday, June 15, 2016 at 12:40 p.m. Central Time.
The presentation will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8® system is designed to support a broad range of
molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor
detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex®. For more information, visit
www.genmarkdx.com.
GenMark Diagnostics, Inc.
Hany Massarany
President, Chief Executive Officer
760-448-4325
View source version on businesswire.com: http://www.businesswire.com/news/home/20160606006442/en/